| Application no. and date | 18804654.4 (espacenet) (Federated) (European Patent Register), 20181127 | | Patent/reg. no. and date | DK/EP 3717916, 20250101 | | Publication date | 20201007 | | Priority no. and date | EP 17204316, 20171129 | | EP pub. no. and date |
EP 3717916 20201007 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | DAHL, Uwe, c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg, DE,
JORDAN, Gregor, c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg, DE,
STAACK, Roland, c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg, DE,
MOHEYSEN-ZADEH, Miriam, c/o Roche Diagnostics GmbH
Nonnenwald 2
82377 Penzberg, DE | | Representative | | | Opponent | | | IPC Class | G01N 33/543 (2006.01) , G01N 33/68 (2006.01) | | Title | TARGET INTERFERENCE SUPPRESSED ANTI-DRUG ANTIBODY ASSAY | | Int. application no. | EP2018082664 | | Int. publication no. | WO2019105916 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
